INFLARX NV

IFRX · NASDAQ

Updated at 2026-10-14 09:06:44

$1.55-2.51%
Today's High
$1.60
Today’s Low
$1.54
INFLARX NV (IFRX) Stock Price & Market Data
Search empty state illustration
...

Candlestick trends are for reference. Refer to the trading page for actual data.

Key Statistics

Previous Open
$1.60
Previous Close
$1.59
Volume
467.92K
Market Cap
$234.31M
P/E Ratio
--
EPS
$-0.34

Previous Day Range

$1.54$1.64

52-Week Range

$0.79$2.94

Company Overview

Sector
HEALTHCARE
Industry
Biotechnology
Sub-industry
BIOTECHNOLOGY
Headquarters
WINZERLAER STR. 2, JENA, GERMANY, 07745
Country
DE
Listing Date
2017-11-08
Fiscal Year End
December
Shares Outstanding
147.29M
CIK
0001708688

InflaRx NV, a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company is headquartered in Jena, Germany.

Financial Metrics

Revenue

2026-06-30

$0

2026-03-31

$0

2025-12-31

-$33.93K

2025-09-30

$23.83K

Operating Expenses

2026-06-30

$7.05M

2026-03-31

$7.2M

2025-12-31

$7.96M

2025-09-30

$9.5M

Net Income

2026-06-30

-$10.64M

2026-03-31

-$5.59M

2025-12-31

-$10.64M

2025-09-30

-$12.26M

Net Profit Margin

2026-06-30

--

2026-03-31

--

2025-12-31

31.36K%

2025-09-30

-51.45K%

Earnings Per Share

2026-06-30

$-0.11

2026-03-31

$-0.08

2025-12-31

$-0.15

2025-09-30

$-0.18

Earnings Before Interest, Taxes, Depreciation, and Amortization

2026-06-30

-$10.54M

2026-03-31

-$5.49M

2025-12-31

-$10.53M

2025-09-30

-$12.13M

Effective Tax Rate

2026-06-30

--

2026-03-31

--

2025-12-31

0.22%

2025-09-30

-0.1%

FAQs

Risk Warning

Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.